(MAS) Masco - Overview
Sector: IndustrialsIndustry: Building Products & Equipment | Exchange NYSE (USA) | Currency USD | Market Cap: 12.255m | Total Return -14% in 12m
Stock: Plumbing Fixtures, Paints, Hardware, Baths, Spas
Total Rating 51
Risk 81
Buy Signal -0.88
| Risk 5d forecast | |
|---|---|
| Volatility | 32.9% |
| Relative Tail Risk | -8.06% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.40 |
| Alpha | -27.49 |
| Character TTM | |
|---|---|
| Beta | 1.093 |
| Beta Downside | 1.194 |
| Drawdowns 3y | |
|---|---|
| Max DD | 30.95% |
| CAGR/Max DD | 0.26 |
EPS (Earnings per Share)
Revenue
Description: MAS Masco March 03, 2026
Masco Corporation (NYSE: MAS) manufactures and distributes home improvement and building products across North America, Europe, and international markets. The company operates through two primary segments: Plumbing Products and Decorative Architectural Products. The Plumbing segment offers fixtures, bathing units, spas, and rough plumbing components under brands such as Delta, Hansgrohe, and Hot Spring. The Decorative Architectural segment produces paints, primers, and hardware, featuring brands like Behr and Kilz.
The company utilizes a multi-channel distribution strategy, selling to home center retailers, wholesalers, and mass merchandisers to reach both professional contractors and Do-It-Yourself (DIY) consumers. As a major player in the building products industry, Mascos revenue is structurally tied to trends in new residential construction and existing home repair and remodel (R&R) spending. For detailed financial modeling and sector comparisons, investors may consult ValueRay.
Headlines to watch out for
- Housing market slowdown impacts plumbing and decorative product demand
- Raw material cost increases squeeze paint and hardware margins
- DIY retail channel strength boosts decorative architectural product sales
- New construction activity drives plumbing product volume
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 810.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.17 > 0.02 and ΔFCF/TA -1.41 > 1.0 |
| NWC/Revenue: 16.75% < 20% (prev 14.95%; Δ 1.81% < -1%) |
| CFO/TA 0.20 > 3% & CFO 1.02b > Net Income 810.0m |
| Net Debt (2.79b) to EBITDA (1.38b): 2.02 < 3 |
| Current Ratio: 1.81 > 1.5 & < 3 |
| Outstanding Shares: last quarter (207.0m) vs 12m ago -3.72% < -2% |
| Gross Margin: 35.40% > 18% (prev 0.36%; Δ 3.50k% > 0.5%) |
| Asset Turnover: 148.0% > 50% (prev 156.1%; Δ -8.03% > 0%) |
| Interest Coverage Ratio: 12.24 > 6 (EBITDA TTM 1.38b / Interest Expense TTM 101.0m) |
Altman Z'' 2.75
| A: 0.24 (Total Current Assets 2.84b - Total Current Liabilities 1.57b) / Total Assets 5.20b |
| B: -0.13 (Retained Earnings -688.0m / Total Assets 5.20b) |
| C: 0.24 (EBIT TTM 1.24b / Avg Total Assets 5.11b) |
| D: -0.04 (Book Value of Equity -186.0m / Total Liabilities 5.13b) |
| Altman-Z'' Score: 2.75 = A |
Beneish M -3.07
| DSRI: 1.03 (Receivables 1.03b/1.03b, Revenue 7.56b/7.83b) |
| GMI: 1.02 (GM 35.40% / 36.18%) |
| AQI: 0.96 (AQ_t 0.18 / AQ_t-1 0.19) |
| SGI: 0.97 (Revenue 7.56b / 7.83b) |
| TATA: -0.04 (NI 810.0m - CFO 1.02b) / TA 5.20b) |
| Beneish M-Score: -3.07 (Cap -4..+1) = AA |
What is the price of MAS shares?
As of March 29, 2026, the stock is trading at USD 59.50 with a total of 2,041,004 shares traded.
Over the past week, the price has changed by +1.12%, over one month by -16.92%, over three months by -7.50% and over the past year by -13.96%.
Over the past week, the price has changed by +1.12%, over one month by -16.92%, over three months by -7.50% and over the past year by -13.96%.
Is MAS a buy, sell or hold?
Masco has received a consensus analysts rating of 3.63.
Therefor, it is recommend to hold MAS.
- StrongBuy: 6
- Buy: 4
- Hold: 13
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the MAS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 80.3 | 35% |
| Analysts Target Price | 80.3 | 35% |
MAS Fundamental Data Overview March 28, 2026
P/E Trailing = 15.5933
P/E Forward = 14.0845
P/S = 1.6206
P/B = 191.8729
P/EG = 1.3156
Revenue TTM = 7.56b USD
EBIT TTM = 1.24b USD
EBITDA TTM = 1.38b USD
Long Term Debt = 2.94b USD (from longTermDebt, last quarter)
Short Term Debt = 49.0m USD (from shortTermDebt, last quarter)
Debt = 3.44b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.79b USD (from netDebt column, last quarter)
Enterprise Value = 15.04b USD (12.26b + Debt 3.44b - CCE 647.0m)
Interest Coverage Ratio = 12.24 (Ebit TTM 1.24b / Interest Expense TTM 101.0m)
EV/FCF = 17.35x (Enterprise Value 15.04b / FCF TTM 867.0m)
FCF Yield = 5.76% (FCF TTM 867.0m / Enterprise Value 15.04b)
FCF Margin = 11.47% (FCF TTM 867.0m / Revenue TTM 7.56b)
Net Margin = 10.71% (Net Income TTM 810.0m / Revenue TTM 7.56b)
Gross Margin = 35.40% ((Revenue TTM 7.56b - Cost of Revenue TTM 4.88b) / Revenue TTM)
Gross Margin QoQ = 33.69% (prev 34.22%)
Tobins Q-Ratio = 2.89 (Enterprise Value 15.04b / Total Assets 5.20b)
Interest Expense / Debt = 0.70% (Interest Expense 24.0m / Debt 3.44b)
Taxrate = 22.47% (51.0m / 227.0m)
NOPAT = 958.3m (EBIT 1.24b * (1 - 22.47%))
Current Ratio = 1.81 (Total Current Assets 2.84b / Total Current Liabilities 1.57b)
Debt / Equity = -18.47 (negative equity) (Debt 3.44b / totalStockholderEquity, last quarter -186.0m)
Debt / EBITDA = 2.02 (Net Debt 2.79b / EBITDA 1.38b)
Debt / FCF = 3.22 (Net Debt 2.79b / FCF TTM 867.0m)
Total Stockholder Equity = -150.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 15.86% (Net Income 810.0m / Total Assets 5.20b)
RoE = -537.3% (negative equity) (Net Income TTM 810.0m / Total Stockholder Equity -150.8m)
RoCE = 44.23% (EBIT 1.24b / Capital Employed (Equity -150.8m + L.T.Debt 2.94b))
RoIC = 33.73% (NOPAT 958.3m / Invested Capital 2.84b)
WACC = 7.80% (E(12.26b)/V(15.69b) * Re(9.83%) + D(3.44b)/V(15.69b) * Rd(0.70%) * (1-Tc(0.22)))
Discount Rate = 9.83% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.87%
[DCF] Terminal Value 80.11% ; FCFF base≈883.0m ; Y1≈941.6m ; Y5≈1.14b
[DCF] Fair Price = 89.06 (EV 20.92b - Net Debt 2.79b = Equity 18.13b / Shares 203.6m; r=7.80% [WACC]; 5y FCF grow 7.38% → 3.0% )
EPS Correlation: 6.79 | EPS CAGR: -3.85% | SUE: 0.25 | # QB: 0
Revenue Correlation: -70.41 | Revenue CAGR: -5.32% | SUE: -0.43 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.31 | Chg7d=-0.001 | Chg30d=-0.002 | Revisions Net=-1 | Analysts=22
EPS current Year (2026-12-31): EPS=4.19 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=-2 | Growth EPS=+5.9% | Growth Revenue=+1.8%
EPS next Year (2027-12-31): EPS=4.63 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=-3 | Growth EPS=+10.3% | Growth Revenue=+3.4%
[Analyst] Revisions Ratio: -0.06 (8 Up / 9 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.4% (Discount Rate 9.8% - Earnings Yield 6.4%)
[Growth] Growth Spread = -2.4% (Analyst 1.1% - Implied 3.4%)
P/E Forward = 14.0845
P/S = 1.6206
P/B = 191.8729
P/EG = 1.3156
Revenue TTM = 7.56b USD
EBIT TTM = 1.24b USD
EBITDA TTM = 1.38b USD
Long Term Debt = 2.94b USD (from longTermDebt, last quarter)
Short Term Debt = 49.0m USD (from shortTermDebt, last quarter)
Debt = 3.44b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.79b USD (from netDebt column, last quarter)
Enterprise Value = 15.04b USD (12.26b + Debt 3.44b - CCE 647.0m)
Interest Coverage Ratio = 12.24 (Ebit TTM 1.24b / Interest Expense TTM 101.0m)
EV/FCF = 17.35x (Enterprise Value 15.04b / FCF TTM 867.0m)
FCF Yield = 5.76% (FCF TTM 867.0m / Enterprise Value 15.04b)
FCF Margin = 11.47% (FCF TTM 867.0m / Revenue TTM 7.56b)
Net Margin = 10.71% (Net Income TTM 810.0m / Revenue TTM 7.56b)
Gross Margin = 35.40% ((Revenue TTM 7.56b - Cost of Revenue TTM 4.88b) / Revenue TTM)
Gross Margin QoQ = 33.69% (prev 34.22%)
Tobins Q-Ratio = 2.89 (Enterprise Value 15.04b / Total Assets 5.20b)
Interest Expense / Debt = 0.70% (Interest Expense 24.0m / Debt 3.44b)
Taxrate = 22.47% (51.0m / 227.0m)
NOPAT = 958.3m (EBIT 1.24b * (1 - 22.47%))
Current Ratio = 1.81 (Total Current Assets 2.84b / Total Current Liabilities 1.57b)
Debt / Equity = -18.47 (negative equity) (Debt 3.44b / totalStockholderEquity, last quarter -186.0m)
Debt / EBITDA = 2.02 (Net Debt 2.79b / EBITDA 1.38b)
Debt / FCF = 3.22 (Net Debt 2.79b / FCF TTM 867.0m)
Total Stockholder Equity = -150.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 15.86% (Net Income 810.0m / Total Assets 5.20b)
RoE = -537.3% (negative equity) (Net Income TTM 810.0m / Total Stockholder Equity -150.8m)
RoCE = 44.23% (EBIT 1.24b / Capital Employed (Equity -150.8m + L.T.Debt 2.94b))
RoIC = 33.73% (NOPAT 958.3m / Invested Capital 2.84b)
WACC = 7.80% (E(12.26b)/V(15.69b) * Re(9.83%) + D(3.44b)/V(15.69b) * Rd(0.70%) * (1-Tc(0.22)))
Discount Rate = 9.83% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.87%
[DCF] Terminal Value 80.11% ; FCFF base≈883.0m ; Y1≈941.6m ; Y5≈1.14b
[DCF] Fair Price = 89.06 (EV 20.92b - Net Debt 2.79b = Equity 18.13b / Shares 203.6m; r=7.80% [WACC]; 5y FCF grow 7.38% → 3.0% )
EPS Correlation: 6.79 | EPS CAGR: -3.85% | SUE: 0.25 | # QB: 0
Revenue Correlation: -70.41 | Revenue CAGR: -5.32% | SUE: -0.43 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.31 | Chg7d=-0.001 | Chg30d=-0.002 | Revisions Net=-1 | Analysts=22
EPS current Year (2026-12-31): EPS=4.19 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=-2 | Growth EPS=+5.9% | Growth Revenue=+1.8%
EPS next Year (2027-12-31): EPS=4.63 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=-3 | Growth EPS=+10.3% | Growth Revenue=+3.4%
[Analyst] Revisions Ratio: -0.06 (8 Up / 9 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.4% (Discount Rate 9.8% - Earnings Yield 6.4%)
[Growth] Growth Spread = -2.4% (Analyst 1.1% - Implied 3.4%)